Migraine with aura is one of the most common conditions mistaken for stroke in emergency rooms. A systematic review found that migraine with aura accounts for roughly 18% of all stroke mimics treated with clot-dissolving medication, and close to 2% of all patients evaluated urgently for possible stroke ultimately turn out to have migraine instead.1PubMed. When migraine mimics stroke: A systematic review The overlap between these two conditions runs deeper than most people realize, touching on shared brain mechanisms, tricky imaging findings, and a genuine biological link that makes the relationship more than just a diagnostic headache.
What a Migraine-Stroke Mimic Actually Looks Like
Migraine aura typically involves visual disturbances, numbness or tingling on one side of the body, and sometimes difficulty speaking. These symptoms develop gradually over several minutes, whereas stroke symptoms usually hit all at once. That textbook distinction, however, breaks down in practice. A person having a prolonged or atypical aura can present with sudden-seeming weakness, slurred speech, and confusion that looks almost indistinguishable from an acute stroke, especially to a bystander or an ER team working against the clock.
Hemiplegic migraine is the most dramatic example. In these attacks, people develop actual motor weakness on one side of their body alongside their headache and other aura symptoms. The weakness can develop over minutes and persist for hours or even days, closely resembling a stroke. Because the standard emergency protocol demands rapid assessment to determine whether a patient qualifies for clot-dissolving therapy, hemiplegic migraine frequently triggers a full stroke workup. Brain imaging becomes essential to separate the two, since a clinical exam alone often cannot.2PubMed Central. Familial Hemiplegic Migraine and Spreading Depression
How Often This Happens in Emergency Rooms
Stroke mimic cases are not rare. In one large series of over 3,100 stroke code activations, about 1.1% turned out to be migraine aura rather than ischemic stroke.3PubMed. Factors associated with migraine aura mimicking stroke in code stroke That percentage sounds small, but stroke codes happen thousands of times daily across hospitals worldwide, which means migraine mimics show up regularly. And among all patients who receive intravenous thrombolysis (the clot-dissolving drug tPA) and turn out not to have had a stroke, migraine is consistently one of the top three diagnoses, alongside seizures and conversion disorder.4PubMed Central. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia
The numbers point to a real tension in emergency medicine. Stroke treatment is extremely time-sensitive, and every minute of delay costs brain tissue. Doctors cannot afford to spend an hour sorting out whether someone is having a migraine before giving treatment, because if the patient is actually having a stroke, that delay could be devastating. The system is deliberately designed to over-treat rather than under-treat, which means some migraine patients will inevitably receive stroke therapy they do not need.
Why the Brain Creates Such Similar Symptoms
The overlap between migraine aura and stroke is not a coincidence. Both involve a phenomenon called cortical spreading depression, a slow wave of electrical and chemical activity that sweeps across the brain’s surface. In migraine, this wave temporarily disrupts normal brain function in the regions it passes through, producing the visual disturbances, numbness, or weakness that characterize aura. In stroke, the same type of spreading depression occurs in the tissue surrounding an area of blocked blood flow, worsening the damage. Strong clinical and experimental evidence links cortical spreading depression to both migraine and stroke, as well as to subarachnoid hemorrhage and traumatic brain injury.5PubMed Central. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury
In migraine, the spreading depression is self-limiting. It sweeps across the cortex, temporarily reduces blood flow, and resolves. In stroke, the blood flow reduction is caused by a blocked artery and does not resolve on its own. But in the early minutes, the brain’s response can look remarkably similar on imaging and at the bedside, which is exactly why the distinction is so hard to make in real time.
What Brain Imaging Shows and Where It Helps
Standard CT scans are often normal in both early stroke and migraine aura, which limits their usefulness in the first critical minutes. Perfusion CT, a specialized scan that maps blood flow through the brain in real time, has proven far more informative. In migraine aura, perfusion imaging typically shows reduced blood flow in cortical areas that correspond to the patient’s symptoms. Two patients initially evaluated for emergency clot-dissolving therapy were found to have hemiplegic migraine after perfusion imaging captured the early phase of their aura, revealing cortical hypoperfusion rather than a blocked vessel.6PubMed. Hemiplegic migraine aura begins with cerebral hypoperfusion: imaging in the acute phase
Researchers have worked to refine what distinguishes migraine hypoperfusion from stroke hypoperfusion on these scans. In a study of 14 migraine aura patients who underwent perfusion CT, nearly all showed measurable reductions in blood flow. Critically, the blood volume values in all of these patients remained above the threshold that would indicate a stroke’s dead tissue core, and the timing of blood flow stayed below the threshold seen in ischemic penumbra, the at-risk tissue surrounding a stroke.7PubMed. A novel computed tomography perfusion-based quantitative tool for evaluation of perfusional abnormalities in migrainous aura stroke mimic In plain terms, migraine reduces blood flow without starving the tissue enough to cause permanent damage, while stroke crosses that line. The perfusion patterns are different, but you need the right scan and a trained eye to spot the difference.
MRI with diffusion-weighted imaging remains the gold standard for confirming stroke. In a true stroke, diffusion-weighted MRI shows restricted water movement in dying brain tissue, a finding that is absent in migraine aura. But getting an MRI during a code stroke takes longer than CT, so perfusion CT has become a practical compromise for the acute window.
Is It Safe to Give Stroke Drugs to Someone Having a Migraine?
This is the question that haunts emergency physicians. The short answer, based on available evidence, is that giving tPA to a migraine patient carries a low risk of harm. The systematic review that quantified migraine mimics among stroke patients found that the reported rate of adverse events from thrombolysis in mimics was extremely low, around 0.01%.8PubMed. When migraine mimics stroke: A systematic review In a separate analysis of stroke mimic patients who received tPA, the mimic group had a median discharge score of zero on the standard stroke severity scale (meaning no residual deficits), and none developed the most feared complication, symptomatic brain hemorrhage.9PubMed Central. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia
That said, “low risk” is not “no risk.” Symptomatic brain hemorrhage can still occur in mimic patients treated with tPA, even if it is uncommon.10PubMed. Migraine as a Stroke Mimic and as a Stroke Chameleon The clinical calculus remains the same: because untreated stroke causes far worse harm than the small risk of treating a mimic, physicians rightly err on the side of giving the drug when uncertainty exists. The goal of better diagnostic tools is not to prevent all mimic treatments but to reduce unnecessary ones without delaying care for actual strokes.
The Reverse Problem: Stroke Disguised as Migraine
The conversation about migraine mimicking stroke tends to overshadow an equally dangerous scenario going the other direction. Stroke can masquerade as migraine, particularly when the stroke presents with headache as a prominent symptom. Among patients sent home from emergency departments with a diagnosis of a non-specific headache disorder, about 0.5% turned out to have been misdiagnosed and were actually having a stroke.11PubMed. Migraine as a Stroke Mimic and as a Stroke Chameleon Half a percent may sound small, but given how many people visit ERs with headaches, the absolute number of missed strokes is concerning.
This “stroke chameleon” problem is especially insidious because it affects the opposite end of the diagnostic spectrum. While the mimic scenario leads to over-treatment (giving unnecessary drugs to migraine patients), the chameleon scenario leads to under-treatment (sending stroke patients home with pain medication). Both directions carry harm, but the chameleon scenario arguably carries more, because delayed stroke treatment can mean permanent disability or death. Clinicians walk a tightrope between these two failure modes every shift.
Telling Migraine Aura Apart from a TIA
Transient ischemic attacks, often called mini-strokes, are another condition that overlaps with migraine aura. Both produce temporary neurological symptoms that resolve completely. A set of explicit diagnostic criteria designed to separate TIAs from migraine with aura achieved a sensitivity of 99% for identifying TIAs and a specificity of 95 to 96% for correctly classifying migraine aura patients.12PubMed. Explicit diagnostic criteria for transient ischemic attacks to differentiate it from migraine with aura
Several features help clinicians lean one way or the other. Migraine aura symptoms tend to build gradually over 5 to 20 minutes, often with a “marching” quality where tingling or visual changes spread progressively. TIA symptoms are more likely to start at maximum intensity. Migraine aura commonly involves positive visual phenomena like shimmering lights or zigzag lines, while TIAs more often cause simple loss of vision. A headache following the neurological symptoms favors migraine, though headache can also accompany stroke. Age matters too: a first-ever episode of aura-like symptoms in someone over 50 with vascular risk factors should raise more concern for TIA than the same symptoms in a 25-year-old with a history of migraine.
Clinical prediction scores with high sensitivity and specificity now exist to help in these assessments, though differentiating migraine aura from TIA remains challenging even with these tools, particularly in older adults who may have both migraine and vascular disease.13PubMed. Migraine as a Stroke Mimic and as a Stroke Chameleon
The Genuine Migraine-Stroke Connection
Beyond mimicry, migraine and stroke are linked biologically. People with migraine, particularly migraine with aura, have a modestly increased risk of ischemic stroke compared to people without migraine. Part of this connection may run through a heart structure called a patent foramen ovale (PFO), a small hole between the heart’s upper chambers that normally closes shortly after birth but remains open in a substantial minority of adults.
Among patients with cryptogenic stroke (stroke with no identified cause) who also had migraine, 79% were found to have a PFO. In those whose migraine included frequent aura, the PFO prevalence climbed to 93%.14PubMed Central. Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke A separate study found that migraine with aura was significantly associated with PFOs classified as probably causal for stroke, with roughly five times the odds compared to patients without migraine. Migraine without aura showed no such association.15Frontiers in Pain Research. Cryptogenic Ischemic Stroke in Migraine: Role of Patent Foramen Ovale The leading theory is that a PFO allows tiny blood clots that would normally be filtered by the lungs to pass directly into the brain’s circulation, a mechanism called paradoxical embolism.
Migraine is also more prevalent among people with other cardiac structural variations, including atrial septal defects and mitral valve prolapse, and the association extends to increased risk for cardiovascular disease more broadly.16PubMed Central. The migraine association with cardiac anomalies, cardiovascular disease, and stroke For most migraine sufferers, the absolute stroke risk remains low. But the connection is real enough that clinicians investigating unexplained strokes in young migraine patients routinely screen for PFO.
Migrainous Infarction: When Migraine Actually Becomes Stroke
In rare cases, a migraine aura does not resolve, and the temporary blood flow reduction crosses the line into actual tissue damage. This is migrainous infarction, defined as a stroke occurring during a migraine with aura attack in which aura symptoms persist for more than 60 minutes and an ischemic brain lesion is confirmed on imaging in the territory matching those symptoms. It accounts for somewhere between 0.2% and 0.5% of all ischemic strokes in large registries.17Journal of Stroke. The Migraine-Stroke Connection
Diagnosis requires a pre-existing history of migraine with aura and an attack that follows the patient’s typical pattern but with aura symptoms that simply do not go away. The criteria are deliberately strict to avoid labeling every stroke in a migraine patient as migrainous infarction. Most strokes that happen to occur in someone with migraine are coincidental or related to shared risk factors like PFO rather than being directly caused by the migraine mechanism itself. The timing of stroke in migraine patients is usually not related to an ongoing migraine attack.18PubMed Central. Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke
Hemiplegic Migraine in Children and Adolescents
Hemiplegic migraine typically begins in childhood or adolescence, making it a particularly important stroke mimic in pediatric emergency settings. Attacks involve headache accompanied by motor weakness that develops over several minutes, often lasting less than an hour before resolving spontaneously without lasting damage.19PubMed. An Important Pediatric Stroke Mimic: Hemiplegic Migraine A child who suddenly cannot move one arm or leg understandably triggers alarm, and the emergency workup for pediatric stroke follows a similar time-pressured protocol to the adult version.
The challenge in children is compounded by the fact that young patients may have difficulty describing their symptoms precisely. A child experiencing visual aura might say “things look weird” rather than describing the classic zigzag lines, and motor weakness may be mistaken for fatigue or behavioral refusal. Familial hemiplegic migraine, which runs in families and is linked to specific gene mutations, can sometimes be identified by family history, which speeds up diagnosis in subsequent attacks. But the first episode almost always requires full imaging to rule out stroke, and rightly so.
Triptans and the Hemiplegic Migraine Debate
Triptans, the most widely prescribed class of migraine-specific medications, work partly by narrowing blood vessels in the brain. Because hemiplegic migraine already involves reduced blood flow during aura, there has long been concern that adding a vasoconstricting drug could worsen the situation or even trigger a stroke. Most drug labels and clinical guidelines have historically advised against using triptans in hemiplegic migraine.
The real-world evidence, though limited, tells a less alarming story. In a survey of 76 people with hemiplegic migraine who had used triptans, the average treatment response was moderately good and no patients experienced a stroke or heart attack. One patient reported prolonged neurological symptoms after a single dose of rizatriptan, but subsequent brain imaging found no signs of damage.20PubMed. Treatment of hemiplegic migraine with triptans A separate retrospective analysis of triptans and dihydroergotamine in hemiplegic and basilar migraine similarly found no cases of stroke or heart attack.21PubMed. A retrospective analysis of triptan and dhe use for basilar and hemiplegic migraine
This remains a gray area. Some specialists will prescribe triptans for hemiplegic migraine when standard pain relief is insufficient, viewing the theoretical risk as outweighed by the practical benefit.22PubMed. Familial and sporadic hemiplegic migraine: diagnosis and treatment Others stick with the conservative approach. The available studies are all retrospective and relatively small, so the safety question is not fully settled, but the feared complication of triptan-induced stroke in hemiplegic migraine has not materialized in published data.
CADASIL and Other Conditions That Blur the Line
Some genetic conditions produce both migraine and stroke as part of the same disease process, making the mimic question moot because both are genuinely happening. The most well-known is CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a hereditary condition affecting small blood vessels in the brain. CADASIL often begins with migraine with aura, sometimes years or decades before the first stroke. Recurrent strokes typically appear between the ages of 30 and 50.23PubMed. CADASIL: hereditary arteriopathy leading to multiple brain infarcts and dementia
In someone with CADASIL, an episode of aura-like symptoms might represent migraine aura, a small vessel stroke, or both simultaneously. The disease progresses to cognitive decline and dementia, and the early migraine phase can go unrecognized for what it is if family history is not explored. Genetic testing confirms the diagnosis. CADASIL is rare, but it illustrates how the migraine-stroke boundary is not always a clean line between two separate conditions. In some patients, the two are manifestations of a single underlying vascular disease.
How the Understanding of Migraine Has Shifted
For most of medical history, migraine was considered fundamentally a vascular disorder. The throbbing quality of the headache, the effectiveness of vasoconstrictive drugs, and the ability to trigger attacks with vasodilating substances all pointed toward blood vessel dysfunction as the root cause. Over the past few decades, that understanding has changed substantially. Research has shown that the vascular changes seen in migraine are more likely a consequence of neural activity than the initiating cause.24PubMed Central. Neurovascular mechanisms of migraine and cluster headache
Key signaling molecules once thought to trigger migraine by dilating blood vessels, including calcitonin gene-related peptide (CGRP), turn out to have effects that extend well beyond the vasculature. They modulate pain-sensing neurons throughout the brain’s trigeminovascular system. The newer class of migraine preventive drugs, CGRP inhibitors, were developed based on this updated understanding. The role of vasodilation in migraine is now considered unclear, with recent findings challenging whether it is even necessary for an attack to occur.25PubMed Central. Neurovascular contributions to migraine: Moving beyond vasodilation Blood vessels may still play a role in migraine through mechanisms other than simple dilation and constriction, including signaling between vascular cells and the nervous system.26Frontiers in Cellular Neuroscience. Vascular Contributions to Migraine: Time to Revisit?
This shift matters for the stroke-mimic question because it reframes what migraine aura actually is. If aura were purely a vascular event (a spasm reducing blood flow), the line between “temporary spasm” and “blocked artery” would be thin and worrying. The neural model suggests that the blood flow changes during aura are secondary to cortical spreading depression, which is a neural event. The brain is driving the show, and the vessels are following. That distinction does not make the clinical confusion any easier to resolve in an emergency room at 3 a.m., but it does help explain why migraine aura so rarely crosses over into actual infarction despite the alarming-looking perfusion changes on brain scans.